Medtronic Vascular Inc 3033 Campus Driveplymouth Mn 55441 Pma Numberp200026 Supplement Numbers005 Date Received06 17 2022 Decision Date07 22 2022 Product Code Qan Advisory Committee Cardiovascular Clinical Trialsnct03038438 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change Pas Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Medtronic Vascular Inc 3033 Campus Driveplymouth Mn 55441 Pma Numberp200026 Supplement Numbers005 Date Received06 17 2022 Decision Date07 22 2022 Product Code Qan Advisory Committee Cardiovascular Clinical Trialsnct03038438 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change Pas Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P200026S005 Medtronic Vascular, Inc.3033 Campus Driveplymouth, MN 55441 PMA NumberP200026 Supplement NumberS005 Date Received06/17/2022 Decision Date07/22/2022 Product Code QAN  Advisory Committee Cardiovascular Clinical TrialsNCT03038438 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Labeling Change - Pas Expedited Review Granted? No	Abre Venous Self-expanding Stent System	2022-07-22